We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Optimizing Starting Material Quality for Cellular Therapeutics

Article   Aug 03, 2018 | by Dominic Clarke, PhD and Marie Aragon, RN, BSN. HemaCare Corporation

 
Optimizing Starting Material Quality for Cellular Therapeutics

Credit: Terumo BCT

 
 
 

RELATED ARTICLES

The Evolving Field of Cancer Biomarkers

Article

Given the complexity of cancer, it’s arguably unlikely that single molecules will work as clinically meaningful biomarkers for cancer. Today, biomarker discovery involves detecting patterns – characteristics or phenotypes that can be measured and monitored throughout a patient’s journey. Here, we look at two approaches being explored in this evolving field.

READ MORE

Sensitivity vs Specificity

Article

When developing diagnostic tests or evaluating results, it is important to understand how reliable those tests and therefore the results you are obtaining are. By using samples of known disease status, values such as sensitivity and specificity can be calculated that allow you to evaluate just that.

READ MORE

Preclinical Modeling of Tumor Metastasis and Resistance: Current Challenges and New Approaches

Article

To improve cancer survival rates, pharma and biotech researchers must develop safe and effective therapies to treat not only primary tumors, but also metastatic growths and tumors that have acquired resistance.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cell Science Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE